Phillip Pang - Feb 22, 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Signature
/s/ Howard Horn, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
Feb 22, 2023
Transactions value $
-$74,750
Form type
4
Date filed
2/24/2023, 07:29 PM
Previous filing
Feb 21, 2023
Next filing
Feb 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Award $0 +60K +42.49% $0.00 201K Feb 22, 2023 Direct F1
transaction VIR Common Stock Sale -$74.8K -2.88K -1.43% $25.97 198K Feb 23, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +70K $0.00 70K Feb 22, 2023 Common Stock 70K $27.01 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
F2 Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
F3 25% of the shares subject to the stock option vest and become exercisable on February 22, 2024, and the remainder vest in 36 equal monthly installments thereafter.